A vaccine study in solid organ transplant patients, found that IL-16 levels (among other cytokines) were significantly lower in subjects with very low antibody response to mRNA-based COVID-19 vaccine compared to subjects with normal immune response, suggesting that this cytokine is associated with the optimal development of humoral immunity after COVID-19 vaccination (42). This evidence concerns the gene IL16 and COVID-19.